New blood-based method rapidly detects brain tumors, researchers say

12/3/2013 | MedicalNewsToday (U.K.)

Scientists from the University of Central Lancashire have devised a blood test to detect brain tumors in 30 minutes. The approach uses analysis of blood samples with infrared light and protein biomarkers to detect glioma serum, a primary brain tumor marker. Infrared light was used to detect molecular vibration, which could help researchers identify whether the gliomas are malignant, according to results published in the journal Analytical and Bioanalytical Chemistry.

View Full Article in:

MedicalNewsToday (U.K.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL